Lupus Erythematosus
Mostrando 1-12 de 1368 artigos, teses e dissertações.
-
1. Como a modificação da dieta pode auxiliar pacientes com Lúpus?
Pacientes com Lúpus Eritematoso Sistêmico (LES) tendem a apresentar triglicerídeos e pressão arterial elevados, aumentando os riscos para desenvolvimento de uma síndrome metabólica (SM). Um estudo mostrou que quando avaliada a presença de SM associada a pacientes com LES, percebeu-se uma prevalência de 26%, podendo variar e 18 a 34%, de acordo com
Núcleo de Telessaúde Maranhão HU-UFMA. Publicado em: 12/06/2023
-
2. Quais são as causas e qual é a investigação inicial de plaquetopenia assintomática?
Plaquetopenia é um achado frequente no hemograma, e nem sempre significa presença de alguma doença. Sempre que não houver uma causa conhecida, e as plaquetas estiverem acima de 50.000 células/mm³, deve-se inicialmente confirmar se a plaquetopenia é real repetindo o exame, para excluir erro laboratorial ou agregação in vitro. Alguns indivíduos t�
Núcleo de Telessaúde Rio Grande do Sul. Publicado em: 12/06/2023
-
3. Predictors of pain catastrophizing in women with systemic lupus erythematosus
SUMMARY OBJECTIVE: The aim of this study was to identify predictive factors associated with pain catastrophizing in women with systemic lupus erythematosus (SLE). METHODS: A total of 104 volunteered women with a diagnosis of systemic lupus erythematosus participated in the study. Pain Catastrophizing Scale, Body Awareness Questionnaire, Tampa Scale of Kine
Revista da Associação Médica Brasileira. Publicado em: 2022
-
4. Risk factors associated with infections in pregnant women with systemic lupus erythematosus
SUMMARY OBJECTIVE: The aim of this study was to analyze the occurrence and risk factors associated with infections during pregnancy in patients with systemic lupus erythematosus. METHODS: This is a retrospective cohort study using the data of pregnant women who were followed up between 2011 and 2018 at a university hospital. RESULTS: The data of 221 pregn
Revista da Associação Médica Brasileira. Publicado em: 2022
-
5. Comment on “Nutritional aspects and cardiovascular risk in systemic lupus erythematosus”
Revista da Associação Médica Brasileira. Publicado em: 2022
-
6. Quality of Life of Pregnant Women with Systemic Lupus Erythematosus
Resumo Objetivo Investigar a qualidade de vida (QV) de gestantes com lúpus eritematoso sistêmico (LES), em acompanhamento ambulatorial pré-natal de alto risco, durante o terceiro trimestre de gestação. Métodos Foi realizado um estudo observacional descritivo em ambulatório de prénatal de alto risco. Asmulheres emacompanhamento pré-natal no terce
Revista Brasileira de Ginecologia e Obstetrícia. Publicado em: 2022
-
7. Mortality in the Elderly Due to Cerebrovascular Disease
Abstract Chloroquine (CQ) and Hydroxychloroquine (HCQ) are antimalarial drugs, with anti-inflammatory properties that justify their use in the treatment of systemic lupus erythematosus and rheumatic diseases. A pandemic caused by the new coronavirus led the entire world’s scientific community to look for drugs already available on the market, capable of ex
Int. J. Cardiovasc. Sci.. Publicado em: 2021-04
-
8. Research and Publication in Brazil: Where we are and Where we Head to
Abstract Chloroquine (CQ) and Hydroxychloroquine (HCQ) are antimalarial drugs, with anti-inflammatory properties that justify their use in the treatment of systemic lupus erythematosus and rheumatic diseases. A pandemic caused by the new coronavirus led the entire world’s scientific community to look for drugs already available on the market, capable of ex
Int. J. Cardiovasc. Sci.. Publicado em: 2021-04
-
9. Effects of Chloroquine and Hydroxychloroquine on the Cardiovascular System - Limitations for Use in the Treatment of COVID-19
Abstract Chloroquine (CQ) and Hydroxychloroquine (HCQ) are antimalarial drugs, with anti-inflammatory properties that justify their use in the treatment of systemic lupus erythematosus and rheumatic diseases. A pandemic caused by the new coronavirus led the entire world’s scientific community to look for drugs already available on the market, capable of ex
Int. J. Cardiovasc. Sci.. Publicado em: 2021-04
-
10. Association between pemphigus and systemic lupus erythematosus: a systematic review and meta-analysis,
Abstract Small vessel vasculitis with anti-proteinase antibodies 3 is an atypical clinical presentation of tuberculosis. The authors present the case of a 47-year-old male patient, with palpable purpura and palmoplantar hemorrhagic blisters, with subsequent dissemination. He presented severe pulmonary symptoms with cavitation, fever, hemoptysis, and high lev
An. Bras. Dermatol.. Publicado em: 2021-03
-
11. Rosettes in T-cell pseudolymphoma: a new dermoscopic finding,
Abstract Rosettes are small white structures visible with polarized light dermoscopy, whose exact morphological correlation is not yet defined. These small shiny structures are found in several conditions such as scarring, dermatofibroma, molluscum contagiosum, squamous cell carcinoma, basal cell carcinoma, melanoma, melanocytic nevus, discoid lupus erythema
An. Bras. Dermatol.. Publicado em: 2021-02
-
12. New Benefits of Hydroxychloroquine in Pregnant Women with Systemic Lupus Erythematosus: A Retrospective Study in a Tertiary Centre
Abstract Objective: To determine pregnancy outcomes in women with systemic lupus erythematosus (SLE) who were treated with hydroxychloroquine in a tertiary center. Methods: A retrospective study involving pregnant women with SLE who had antenatal follow-up and delivery in between 1 January 2007 and 1 January 2017. All participants were retrospectively enro
Rev. Bras. Ginecol. Obstet.. Publicado em: 2020-11